Abstract
A meta-analysis of epidemiological studies reported no increased risk for cancer in users of thiazolidinediones; however, subanalyses showed a small 1.1- to 1.2-fold increased risk for bladder cancer with thiazolidinedione use. This analysis was probably distorted by “duplicate publication bias.”
| Original language | English |
|---|---|
| Article number | 1147 |
| Number of pages | 1 |
| Journal | Oncologist |
| Volume | 18 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2013 |
Keywords
- BLADDER-CANCER
- METAANALYSIS
- RISK
- PIOGLITAZONE